Evidence map›Paper›PMID 33598409›Full record

ArticleToxicology reports2021

Zebrafish and

Natalie Álvarez-Alarcón, Jhon Jairo Osorio-Méndez, Adis Ayala-Fajardo, William F Garzón-Méndez, Zayra V Garavito-Aguilar

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Sublethal Concentrations of 2C-I and 25I-NBOMe Designer Drugs ImpactInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Review
  6. Assessment of Anticancer Properties ofPlants (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Natalie Álvarez-AlarcónLaboratory of Developmental Biology, Department of Biological Sciences, Universidad de los Andes, Cra. 1 # 18A-12, Bloque A, Oficina 308, Bogotá D.C, 111711, Colombia.
Jhon Jairo Osorio-MéndezLaboratory of Developmental Biology, Department of Biological Sciences, Universidad de los Andes, Cra. 1 # 18A-12, Bloque A, Oficina 308, Bogotá D.C, 111711, Colombia.
Adis Ayala-FajardoGrupo de Investigación de Bioquímica y Biología Molecular, Facultad de Ciencias y Educación, Licenciatura en Química, Universidad Distrital Francisco José de Caldas, Cra. 4 # 26B-54, 5th Floor, Bogotá D.C., Colombia.
William F Garzón-MéndezChemistry Group, Central-Level, Fiscalía General de la Nación, Diagonal 22B # 52-01, Building L, 3rd Floor, Bogotá D.C., Colombia.
Zayra V Garavito-AguilarLaboratory of Developmental Biology, Department of Biological Sciences, Universidad de los Andes, Cra. 1 # 18A-12, Bloque A, Oficina 308, Bogotá D.C, 111711, Colombia.
Universidad de Los Andes · COUniversidad Distrital Francisco José de Caldas · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The NBOMe (N-2-methoxybenzyl-phenethylamines) family of compounds are synthetic hallucinogens derived from the 2C series. Although this family of compounds has been responsible for multiple cases of acute toxicity and several deaths around the world, to date there are few studies. These compounds act as potent 5-HT

Indexed as

25C-NBOMeArtemia salinaTeratogenic effectsToxicityZebrafish

Identifiers

PMID33598409
PMCPMC7868744
OpenAlexW3123949134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.